Acute Myeloid Leukemia: Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 59-year-old male who presented with gum swelling and bleeding, an abnormal CBC, and physical examination was remarkable for gingival hyperplasia as well as 1-2 cm bilateral cervical and submandibular adenopathy. Review of the peripheral smear demonstrated frequent blasts and promonocytes. Immature monocytes and neutrophils with hypersegmented nuclei and occasionally with hypogranular cytoplasm were present. There was a macrocytic anemia with anisocytosis and a moderate thrombocytopenia with hypogranular forms seen. Originally posted on a forum in the ASCO Connection, participants now have the opportunity to claim CME, completion, or participation certificates for completing this activity.

Learning Objectives

  • Recognize the clinical characteristics and outcomes for patients with FLT3 mutations
  • Describe the role of FLT3 inhibitors for the initial treatment of AML
  • Understand the role of gene mutations, including CLT3, in the pathologic classification of AML

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™ 
  • ABIM MOC Points
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on November 9, 2019. Participants must complete all necessary course components by this date to receive credit.